Show simple item record

dc.contributor.advisorMichelle Trivedi, MD, MPH
dc.contributor.authorTrivedi, Michelle
dc.contributor.authorHoque, Shushmita
dc.contributor.authorLuther, Janki
dc.contributor.authorSpano, Michelle
dc.contributor.authorShillan, Holly
dc.contributor.authorPearl, Hallie
dc.contributor.authorSeay, Hannah L.
dc.contributor.authorPhipatanakul, Wanda
dc.contributor.authorGerald, Lynn B.
dc.contributor.authorPbert, Lori
dc.date2022-08-11T08:10:56.000
dc.date.accessioned2022-08-23T17:25:15Z
dc.date.available2022-08-23T17:25:15Z
dc.date.issued2021-09-01
dc.date.submitted2021-09-21
dc.identifier.citation<p>Trivedi M, Hoque S, Luther J, Spano M, Shillan H, Pearl H, Seay H, Phipatanakul W, Gerald LB, Pbert L. Incorporating systems-level stakeholder perspectives into the clinical trial design of school-supervised asthma therapy. Contemp Clin Trials. 2021 Sep;108:106510. doi: 10.1016/j.cct.2021.106510. Epub 2021 Jul 16. PMID: 34280575; PMCID: PMC8453113. <a href="https://doi.org/10.1016/j.cct.2021.106510">Link to article on publisher's site</a></p>
dc.identifier.issn1551-7144 (Linking)
dc.identifier.doi10.1016/j.cct.2021.106510
dc.identifier.pmid34280575
dc.identifier.urihttp://hdl.handle.net/20.500.14038/49366
dc.description<p>Shushmita Hoque participated in this study as a medical student in the Senior Scholars research program at the University of Massachusetts Medical School.</p>
dc.description.abstractRATIONALE: Few evidence-based public health interventions are adopted in practice, in part due to a disconnect between the outcomes measured in clinical trials and the outcomes important to stakeholders that determine implementation in real-world practice. AsthmaLink is a school-supervised asthma therapy program which partners pediatric providers, school nurses, and families. To inform the design of a cluster randomized controlled trial of AsthmaLink, we elicited systems-level stakeholder input. METHODS: Maximum variation sampling was used to recruit 18 stakeholders to participate in semi-structured interviews that were recorded, transcribed, and open coded: Department of Public Health officials (n = 4), school officials (n = 4), pediatric practice managers (n = 3), health insurance officials (n = 4), and legislators (n = 3). Thematic analysis was used to identify common themes related to stakeholder priorities for clinical trial design and perceived barriers to AsthmaLink adoption. RESULTS: Stakeholder groups identified common priorities for the clinical trial design, including examination of the extent to which AsthmaLink (1) reduces health care utilization, (2) is cost effective (2) addresses health disparities, (3) reduces school absenteeism, and (4) educates families about asthma. Stakeholder groups reported potential barriers to AsthmaLink adoption, including challenges pertaining to (1) securing resources, staffing, and reimbursement, (2) variability across school districts, and (3) standing out amidst multiple programs vying for resources. CONCLUSIONS: Systems-level stakeholder input informed refinements to the clinical trial design of a school-supervised therapy program including outcome and implementation measures and choice of study population. Incorporating systems-level stakeholder perspectives into clinical trial design is critical to achieve adoption of evidence-based interventions into practice.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=34280575&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1016/j.cct.2021.106510
dc.subjectChildhood asthma
dc.subjectClinical trial design
dc.subjectImplementation
dc.subjectStakeholder engagement
dc.subjectUMCCTS funding
dc.subjectClinical Trials
dc.subjectCommunity-Based Research
dc.subjectMedical Education
dc.subjectPediatrics
dc.subjectPublic Health
dc.subjectPulmonology
dc.subjectRespiratory Tract Diseases
dc.titleIncorporating systems-level stakeholder perspectives into the clinical trial design of school-supervised asthma therapy
dc.typeJournal Article
dc.source.journaltitleContemporary clinical trials
dc.source.volume108
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/ssp/305
dc.identifier.contextkey25048481
html.description.abstract<p>RATIONALE: Few evidence-based public health interventions are adopted in practice, in part due to a disconnect between the outcomes measured in clinical trials and the outcomes important to stakeholders that determine implementation in real-world practice. AsthmaLink is a school-supervised asthma therapy program which partners pediatric providers, school nurses, and families. To inform the design of a cluster randomized controlled trial of AsthmaLink, we elicited systems-level stakeholder input.</p> <p>METHODS: Maximum variation sampling was used to recruit 18 stakeholders to participate in semi-structured interviews that were recorded, transcribed, and open coded: Department of Public Health officials (n = 4), school officials (n = 4), pediatric practice managers (n = 3), health insurance officials (n = 4), and legislators (n = 3). Thematic analysis was used to identify common themes related to stakeholder priorities for clinical trial design and perceived barriers to AsthmaLink adoption.</p> <p>RESULTS: Stakeholder groups identified common priorities for the clinical trial design, including examination of the extent to which AsthmaLink (1) reduces health care utilization, (2) is cost effective (2) addresses health disparities, (3) reduces school absenteeism, and (4) educates families about asthma. Stakeholder groups reported potential barriers to AsthmaLink adoption, including challenges pertaining to (1) securing resources, staffing, and reimbursement, (2) variability across school districts, and (3) standing out amidst multiple programs vying for resources.</p> <p>CONCLUSIONS: Systems-level stakeholder input informed refinements to the clinical trial design of a school-supervised therapy program including outcome and implementation measures and choice of study population. Incorporating systems-level stakeholder perspectives into clinical trial design is critical to achieve adoption of evidence-based interventions into practice.</p>
dc.identifier.submissionpathssp/305
dc.contributor.departmentPrevention Research Center
dc.contributor.departmentSenior Scholars Program
dc.contributor.departmentSchool of Medicine
dc.contributor.departmentDepartment of Population and Quantitative Health Sciences
dc.contributor.departmentDivision of Pulmonary Medicine, Department of Pediatrics
dc.source.pages106510


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record